Catalyst Wire Dossier Catalyst Wire Dossier

BIIR 561 CL

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BIIR 561 CL, covering 2014-08-22 to 2014-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers [Phase 1]

See pricing